Jonker Sonnet S, Faber J Job, Anderson Debra F, Thornburg Kent L, Louey Samantha, Giraud George D
Heart Research Center, Oregon Health and Science University, Portland, Oregon, USA.
Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R913-9. doi: 10.1152/ajpregu.00484.2006. Epub 2006 Oct 5.
While the fetal heart grows by myocyte enlargement and proliferation, myocytes lose their capacity for proliferation in the perinatal period after terminal differentiation. The relationship between myocyte enlargement, proliferation, and terminal differentiation has not been studied under conditions of combined arterial and venous hypertension, as occurs in some clinical conditions. We hypothesize that fetal arterial and venous hypertension initially leads to cardiomyocyte proliferation, followed by myocyte enlargement. Two groups of fetal sheep received intravascular plasma infusions for 4 or 8 days (from 130 days gestation) to increase vascular pressures. Fetal hearts were arrested in diastole and dissociated. Myocyte size, terminal differentiation (%binucleation), and cell cycle activity (Ki-67[+] cells as a % of mononucleated myocytes) were measured. We found that chronic plasma infusion greatly increased venous and arterial pressures. Heart (but not body) weights were approximately 30% greater in hypertensive fetuses than controls. The incidence of cell cycle activity doubled in hypertensive fetuses compared with controls. After 4 days of hypertension, myocytes were (approximately 11%) longer, but only after 8 days were they wider (approximately 12%). After 8 days, %binucleation was approximately 50% greater in hypertensive fetuses. We observed two phases of cardiomyocyte growth and maturation in response to fetal arterial and venous hypertension. In the early phase, the incidence of cell cycle activity increased and myocytes elongated. In the later phase, the incidence of cell cycle activity remained elevated, %binucleation increased, and cross sections were greater. This study highlights unique fetal adaptations of the myocardium and the importance of experimental duration when interpreting fetal cardiac growth data.
虽然胎儿心脏通过心肌细胞增大和增殖而生长,但心肌细胞在终末分化后的围产期失去增殖能力。在一些临床情况下出现的动脉和静脉联合高血压条件下,尚未研究心肌细胞增大、增殖和终末分化之间的关系。我们假设胎儿动脉和静脉高血压最初会导致心肌细胞增殖,随后是心肌细胞增大。两组胎羊在妊娠130天开始接受血管内血浆输注4天或8天,以升高血管压力。将胎儿心脏停搏于舒张期并解离。测量心肌细胞大小、终末分化(双核化百分比)和细胞周期活性(Ki-67[+]细胞占单核心肌细胞的百分比)。我们发现慢性血浆输注显著升高了静脉和动脉压力。高血压胎儿的心脏(而非身体)重量比对照组大约重30%。与对照组相比,高血压胎儿的细胞周期活性发生率翻倍。高血压4天后,心肌细胞变长(约11%),但仅在8天后变宽(约12%)。8天后,高血压胎儿的双核化百分比大约高50%。我们观察到胎儿动脉和静脉高血压导致心肌细胞生长和成熟的两个阶段。在早期阶段,细胞周期活性发生率增加,心肌细胞伸长。在后期阶段,细胞周期活性发生率保持升高,双核化百分比增加,横截面积增大。这项研究突出了心肌独特的胎儿适应性以及在解释胎儿心脏生长数据时实验持续时间的重要性。